Listen & view PVI, PeerView Institute for Medical Education's lyrics & tabs

...read more

Top Tracks of PVI, PeerView Institute for Medical Education

Scott H. Kollins, PhD, MS - Insights on Adult ADHD: Recognition, Diagnosis, and Treatment

Michael J. Gitlin, MD - Differentiating Bipolar Disorder From Major Depressive Disorder: A Case-Based Approach to Improving Diagnosis and Treatment in Primary Care

Robert G. Gish, MD - Taking Stock of the Current Research in Hepatocellular Carcinoma

Pierre Tariot, MD - Improving the Quality of Patient Screening, Timely Diagnosis, and Institution of Therapy for Alzheimer’s Disease Among Minority Populations in the Community and Long-Term Care Settings

Jorge Cortes, MD - Questioning Clinical Assumptions in Accelerated-Phase and Blast-Crisis CML

Deepak L. Bhatt, MD, MPH - Maximizing ACS Outcomes in 2012: Best Practices in a Complex Treatment Environment

Ian A. Cook, MD - Applying Evidence to Practice in Major Depressive Disorder: An Interactive Panel Discussion

Perry G. Fine, MD - Practical Considerations in Management of Chronic Pain

Henry S. Friedman, MD - Assessing the Safety and Efficacy of Emerging Therapies in Newly Diagnosed and Recurring Glioblastoma Multiforme: Latest Results From Orlando

Robert S. Gaston, MD - Immunosuppression for Kidney Transplant Recipients: How to Maximize Outcomes and Minimize Graft Failure

Craig Kessler, MD - Managing the Adult Hemophilia Patient With Inhibitors: A Roundtable Discussion

Hope S. Rugo, MD - Current Research on New Treatments for Patients With Difficult-to-Treat Advanced Breast Cancer: An Interact

G. David Roodman, MD, PhD - Optimizing Bone Health Management in Multiple Myeloma

Aaron Boster, MD - Improving Outcomes in Multiple Sclerosis Through the Practice of Shared Decision-Making in Disease-Modifying Therapy Selection

Hope S. Rugo, MD - New Insights Into Efficacy, Safety, and Optimal Use of Endocrine Therapies in Breast Cancer

Peter Hillmen, MD - Achieving Optimal Management of High-Risk CLL

Hans-Joachim Schmoll, MD, PhD - Re-Evaluating Therapeutic Options for the Prevention and Management of CINV

Rodger D. MacArthur, MD - Improving the Management of HIV-Associated Diarrhea

Gail J. Roboz, MD - Evaluating Research-Driven Therapeutic Advances in Hematologic Malignancies

Jedd D. Wolchok, MD, PhD, - Novel Immunotherapy in Malignant Melanoma: Changing the Nature of Modern Treatment

John P. Leonard, MD - Innovative Therapy for NHL and CLL: How Cutting-Edge Research Is Influencing Modern Management

John Porter, MD, FRCP - Evaluating New Data in Iron Overload: Updates on Chelation Therapy in Transfusional Disease

Kevin N. Sheth, MD - Exploring Unmet Needs in Large Hemispheric Infarction: Clinical Insights on Early Recognition and Emerging Therapy

Kim Lawson, PhD - Uncovering Mysteries of Fibromyalgia Syndrome as a Pain Condition

Rhonda R. Voskuhl, MD - Optimizing Treatment to Delay Disease Progression and Preserve Cognitive Function: A Review of Established and Emerging Therapies for MS

Edith A. Perez, MD - Finding Ways to Prevent, Circumvent, or Overcome Cardiovascular Toxicity Associated With Modern Breast Ca

Axel Grothey, MD - Modifying Treatment, Maximizing Benefit: A Case-Based Exploration of Advanced CRC Management

Mark A. Socinski, MD - Assessing Maintenance Therapy in Advanced NSCLC: Is it True Maintenance or Exposure to Active Treatment

Joseph I. Sirven, MD - Generalized Tonic-Clonic Seizures: Clinical Pearls for Recognition and Optimal Management

John L. Marshall, MD - Contrasting Strategies for Managing the Elderly Patient With Advanced Colorectal Cancer

Richard I. Fisher, MD - Evaluating Innovative Strategies in Relapsed/Refractory Mantle-Cell Lymphoma

Robert J. Motzer, MD - Established and Emerging Therapies for Renal Cell Carcinoma: Clinical Highlights From the 2009 Meeting

Edward J. Fox, MD, PhD - Personalizing Disease-Modifying Therapy for Multiple Sclerosis in the Era of Expanding Treatment Options and Potential Biomarkers

Thomas J. Lynch Jr., MD - Can Emerging Targeted Strategies Improve Outcomes in Advanced NSCLC?

Adam Boxer, MD - Progressive Supranuclear Palsy: Examining Diagnostic Considerations and Emerging Treatment Approaches

Robert Rifkin, MD, FACP - Managing Treatment- and Disease-Related Complications in Multiple Myeloma

Stuart Isaacson, MD - An Expert’s Perspective on the Diagnosis and Management of Parkinson’s Disease Psychosis in the Long-Term Care Setting

Gavin Giovannoni, MBBCH, PhD, FCP, FRCP, FRCPath - Highly Effective Disease-Modifying Therapies for Multiple Sclerosis: When and In Whom Should They Be Used?

Barry Singer, MD - Examining the Clinical Implications of Late-Breaking Data on Approved and Emerging Disease-Modifying Therapies for Multiple Sclerosis Management: What Are the Key Learnings From Boston?

Claire S. Riley, MD - Navigating the Present and Advancing the Future of Multiple Sclerosis Management Across Patient Phenotypes—Harnessing the Full Potential of Current and Emerging Therapies in Relapsing and Progressive Disease

Michael J. Gitlin, MD - Differentiating Between Schizophrenia and Bipolar Disorder: A Closer Look at Overlapping Symptoms

Richard J. Barohn, MD - Taking Stock of Recent Clinical Research in Generalized Myasthenia Gravis: What Is the Potential Impact of New Therapies on Disease Management?

Joseph McEvoy, MD - Advances in Tardive Dyskinesia: A Patient's Journey From Diagnosis to Management and the Role of New Therapies for Improved Outcomes

Steve Chung, MD - Improving Outcomes in Patients With Primary Generalized Tonic-Clonic Seizures Through Evidence-Based Treatments and Personalized Approaches

Todd Dylan Levine, MD - Navigating the Patient Journey From CIDP Diagnosis Through Initial Treatment and Onto Long-Term Maintenance Therapy

Farhad Ravandi, MD - Assessing the Clinical Role of Bispecific Antibody Immunotherapy in Addressing Unmet Needs in ALL

Eric Donnenfeld, MD - Deciphering Dry Eye Syndrome and Ocular Allergy: Accurate Diagnosis and Appropriate Treatment

Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA, FECMM - Preventing and Managing Cytomegalovirus and Invasive Fungal Infection After Hematopoietic Stem Cell Transplantation: Key Questions, Expert Answers

Nicola A. Hanania, MD, MS - New Developments in the Treatment of Asthma: Updates From Denver

Dimitrios P. Kontoyiannis, MD, MS, ScD, FACP, FIDSA - Minimizing the Burden of Invasive Fungal Infections: Practical Strategies to Improve Outcomes in the Inpatient Setting

Edith A. Perez, MD - The "Golden Age" of HER2-Targeted Therapy for Breast Cancer: Translating Evidence to Practice to Improve Outcomes in Early-Stage and Advanced HER2-Positive Disease

John W. Eikelboom, MD - A New Look at Stroke Prevention in Atrial Fibrillation: A Review of Novel Oral Anticoagulants

Flavio Vincenti, MD - A New Era of Immunosuppression: A Roundtable Discussion of Individualizing Post-Transplant Management

Edith A. Perez, MD - The "Golden Age" of HER2-Targeted Therapy for Breast Cancer: Translating Evidence to Practice to Improve Outcomes in Early-Stage and Advanced HER2-Positive Disease

Shehzad Rehman, MD - Hot Topics in Kidney Transplantation: A Focus on Donor-Recipient Matching, Antibody Desensitization, and Current and Emerging Immunosuppressive Therapies

Shehzad Rehman, MD - Hot Topics in Kidney Transplantation: A Focus on Post-Transplant Comorbidities, Antibody-Mediated Rejection, and Opportunistic Infection

John W. Eikelboom, MD - A New Look at Stroke Prevention in Atrial Fibrillation: A Review of Novel Oral Anticoagulants

Hope S. Rugo, MD - Current Research on New Treatments for Patients With Difficult-to-Treat Advanced Breast Cancer: An Interactive Discussion of Challenges, Opportunities, and Practical Considerations

Farhad Ravandi-Kashani, MD - A New Wave of Therapy in Adult AML? Individualized Treatment Strategies and the Implications of New Science

Fred D. Lublin, MD, FAAN - Exploring the Practical Applications of Imaging in the Diagnosis and Management of MS: A Case-Based

Richard J. Kelly, MBChB, MRCP(UK), FRCPath - Driving Optimal Treatment of Paroxysmal Nocturnal Hemoglobinuria

Arthur Kavanaugh, MD - Early, Aggressive, and Appropriate Management of Rheumatoid Arthritis: Focus

Margaret von Mehren, MD - The Modern Approach to Soft-Tissue and Bone Sarcomas: Is Innovative Therapy Possible?

Antoni Ribas, MD - The Future Is Now in Melanoma: Exploring Strategies for Innovative Care Based on New Science

William J. Gradishar, MD - Patient Scenarios for Everyday Practice: Managing Advanced HER2-Positive Breast Cancer Throughout t

Daniel J. Clauw, MD - Improving Patient Outcomes in Fibromyalgia Syndrome: A Clinical Update on Appropriate Diagnosis, Adequate Treatment, and Proper Management of Comorbid Conditions

Marvin Dewar, MD - Educating Physicians About Modern-Day Education: Dispelling The Myths and Providing The Facts About Commercially Supported CME

Rene Westhovens, MD, PhD - Advances in Management of Early Rheumatoid Arthritis: Where Are We Now, and Where Are We Going?

Bernard J. Escudier, MD - Expanding Options for First-Line Treatment of Advanced Kidney Cancer: How Can We Choose the Right Tr

Alan B. Sandler, MD - Current and Emerging Role of Antiangiogenic Therapy in Lung Cancer

Maurie Markman, MD - Expert Perspectives on Challenges, Controversies, and Opportunities in Ovarian Cancer Therapy: The Present and the Future

Andre Goy, MD - Expanding Treatment Options for Relapsed/Refractory Follicular Lymphoma

Corey J. Langer, MD, FACP - An Interactive Debate on Maintenance Therapy in Advanced NSCLC: When Should We Use Maintenance, an

Axel Grothey, MD - Exploring the Potential of Targeted Adjuvant Treatment and Individualized Therapy in Colorectal Cancer: Les

Kenneth Anderson, MD - State of the Science in Multiple Myeloma: Which New Therapies Have Convincingly Demonstrated Improvemen

Charles B. Nemeroff, MD - Managing Depression and Antidepressant Drug-Drug Interactions

Robert J. Motzer, MD - Clinical and Research Advances in Renal Cell Carcinoma: Updates From the 2009 Genitourinary Cancers Sym

Louis Monnier, MD - A Debate on Glycaemic Control in Type 2 Diabetes: Maintaining Target A1c, Postmeal Glucose, and Therapy Selection

Daniel J. Clauw, MD - Optimal Management of Fibromyalgia: Trends in Diagnosis and Treatment

Lewis J. Rubin, MD - Pulmonary Arterial Hypertension: Exploring Various Etiologies and New Evidence on Treatment Options

Vivian A. Fonseca, MD, FRCP - Matching Treatment to Need in Type 2 Diabetes: Using Incretin-Based Oral Therapies Across the Clin

Corey J. Langer, MD, FACP - An Interactive Debate on Maintenance Therapy in Advanced NSCLC: When Should We Use Maintenance, and Which Patients Benefit?

Maurie Markman, MD - Expert Perspectives on Challenges, Controversies, and Opportunities in Ovarian Cancer Therapy: The Presen

Buffering (0%)...

Eric M. Ruderman, MD - The Role of Risk Evaluation and Mitigation Strategies for TNF Blockers in Autoimmune Diseases

Ian A. Cook, MD - Ensuring Proper Diagnosis and Effective Treatment in Mood Disorders: Practical Considerations for the Enhance

Ruth M. Benca, MD, PhD - The Science of Improving Sleep: Updates on Managing Insomnia

Jerome Engel, Jr., MD, PhD - Improving Epilepsy Management Throughout the Disease Continuum

Leonard B. Saltz - Clinical Update on Cytotoxic and Targeted Biologic Agents in the Treatment of Metastatic Colorectal Cancer

Robert J. Motzer, MD - mTOR Inhibitors in RCC and Other Solid Tumors: Preventing Deleterious Effects of Abnormal Signaling in Key Pathways

William J. Gradishar, MD - Patient Scenarios for Everyday Practice: Managing Advanced HER2-Positive Breast Cancer Throughout the Disease Continuum

Carol S. Viele, MS, RN and Sunil Sharma, MD - Antiangiogenic Therapy in Lung and Colorectal Cancer: Patient Scenarios for Everyday Practice